Mesoblast
(NASDAQ) MESO
Mesoblast Financials at a Glance
Market Cap
$2.09B
Revenue (TTM)
$17.20M
Net Income (TTM)
$102.14M
EPS (TTM)
$-0.74
P/E Ratio
-21.94
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$15.70
Volume
70,923.257
Open
$15.98
Price
$15.70
Volume
70,923.257
Open
$15.98
Previous Close
$16.18
Daily Range
$15.63 - $16.00
52-Week Range
$9.88 - $21.50
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$15.70
Volume
70,923.257
Open
$15.98
Previous Close
$16.18
Daily Range
$15.63 - $16.00
52-Week Range
$9.88 - $21.50
MESO News
Why Mesoblast Stock Plummeted on Friday
MESO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mesoblast
Industry
Biotechnology
Sector
Health CareEmployees
81
CEO
Silviu Itescu, PhD
Website
www.mesoblast.comHeadquarters
Melbourne, VIC 3000, AU
MESO Financials
Key Financial Metrics (TTM)
Gross Margin
-2%
Operating Margin
-6%
Net Income Margin
-5%
Return on Equity
-18%
Return on Capital
-14%
Return on Assets
-10%
Earnings Yield
-4.56%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.09B
Shares Outstanding
129.28M
Volume
70.92K
Short Interest
0.00%
Avg. Volume
257.11K
Financials (TTM)
Gross Profit
$12.07M
Operating Income
$62.44M
EBITDA
$73.66M
Operating Cash Flow
$49.95M
Capital Expenditure
$730.00K
Free Cash Flow
$50.68M
Cash & ST Invst.
$161.16M
Total Debt
$128.16M
Mesoblast Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.02M
+458.6%
Gross Profit
$16.23M
-69.4%
Gross Margin
-2.31%
N/A
Market Cap
$2.09B
N/A
Market Cap/Employee
$28.65M
N/A
Employees
73
N/A
Net Income
$27.10M
+2.2%
EBITDA
$19.64M
-28.7%
Quarterly Fundamentals
Net Cash
$5.57M
+93.7%
Accounts Receivable
$43.30M
+2465.2%
Inventory
$21.66M
-10.5%
Long Term Debt
$66.02M
-37.8%
Short Term Debt
$69.12M
+247.6%
Return on Assets
-9.99%
N/A
Return on Invested Capital
-13.66%
N/A
Free Cash Flow
$15.69M
-51.2%
Operating Cash Flow
$15.56M
-50.6%